Rabbit EZH2 Polyclonal Antibody | anti-EZH2 antibody

EZH2 Antibody

Cat. Num. AAA840684

• Reactivity: Human, Mouse, Rat
• Applications: Western Blot
• Purity: Affinity purified
• Synonyms: EZH2; Polyclonal Antibody; EZH2 Antibody; Enhancer of zeste homolog 2 (ENX-1); isoform CRA_b; anti-EZH2 antibody

• Host: Rabbit
• Reactivity: Human, Mouse, Rat
• Clonality: Polyclonal
• Isotype: IgG
• Purity/Purification: Affinity purified
• Form/Format: 100 ug (0.5 mg/ml) affinity purified rabbit anti- EZH2 polyclonal antibody in phosphate buffered saline (PBS), pH 7.2, containing 30% glycerol, 0.5% BSA, 5 mM EDTA and 0.01% thimerosal.; Appearance: Colorless liquid
• Concentration: 0.5 mg/ml (varies by lot)
• Sequence Length: 746

• Applicable Applications for anti-EZH2 antibody: Western Blot (WB)
• Application Notes: Western Blot analysis (0.5-4 ug/ml). However, the optimal concentrations should be determined individually. Blocking peptide is available separately.
• Immunogen: Synthetic peptide mapping to the N-terminus of rat Ezh2
• Positive Control: Rat kidney tissue lysate
• Handling: The antibody solution should be gently mixed before use.
• Preparation and Storage: At -20 degree C; Shelf Life: 12 months

Testing Data

Related Product Information for anti-EZH2 antibody

Background: Enhancer of zeste homolog 2 (Ezh2) is a member of the Polycomb group (PcG). The PcG proteins are involved in maintaining the silenced state of several developmentally regulated genes and contribute to the maintenance of cell identity, cell cycle regulation, and oncogenesis. Enhancer of zeste homolog 2 (Ezh2) contains four conserved regions including domain I, domain II, and a cysteine-rich amino acid stretch that precedes the carboxy-terminal SET domain. Ezh2 also plays a role as primary effector and as a mediator of tumorigenesis.

Product Categories/Family for anti-EZH2 antibody

Epigenetics; SIRTs; > (ADD NEW ANTIBODY CATEGORY) Antibodies & Supporting Tools; Primary Antibodies (A-Z)

NCBI and Uniprot Product Information

• NCBI GI #: 201066405
• NCBI GeneID: 312299
• NCBI Accession #: NP_001128451.1
• NCBI GenBank Nucleotide #: NM_001134979.1
• UniProt Accession #: B5DFE2
• Molecular Weight: 85,251 Da
• NCBI Official Full Name: histone-lysine N-methyltransferase EZH2
• NCBI Official Synonym Full Names: enhancer of zeste 2 polycomb repressive complex 2 subunit
• NCBI Official Symbol: Ezh2
• NCBI Protein Information: histone-lysine N-methyltransferase EZH2
• UniProt Protein Name: Ezh2 protein
• Protein Family: Histone-lysine N-methyltransferase
• UniProt Gene Name: Ezh2
• UniProt Entry Name: B5DFE2_RAT

Uniprot Description

EZH2: a histone H3 Lys 27 (H3K27) methyltransferase and Polycomb group protein with oncogenic activity. A master regulatory protein that plays a critical role in development. Catalytic subunit of the PRC2/EED-EZH2 complex, which methylates K9 and K27 of histone H3, leading to transcriptional repression of the affected target genes. PRC2 includes the Ezh2, EED, SUZ12, RBBP4 and RBBP7 and possibly AEBP2. The recruitment of PRC2 to a promoter leads to increased levels of di- and trimethylation of H3K27 (H3K27me2/3), regulating the balance between self-renewal and differentiation of embryonic stem cells (ESCs). The recruitment of PRC2 to promoters in ES cells is interdependent on Jarid 2. ESCs lacking the PRC2 component EED are deficient in Jarid2 promoter activity, while the knockdown of Jarid 2 reduces PRC2 at its target promoters. Able to mono-, di- and trimethylate K27 of histone H3 to form H3K27me1, H3K27me2 and H3K27me3, respectively. Genes repressed by the PRC2/EED-EZH2 complex include HOXC8, HOXA9, MYT1, p14ARF and retinoic acid target genes. Binds ATRX via the SET domain. The PRC2 complex may also interact with DNMT1, DNMT3A, DNMT3B and PHF1 via the EZH2 subunit and with SIRT1 via the SUZ12 subunit. Interacts with HDAC1 and HDAC2. Interacts with PRAME. Overexpressed in numerous tumor types including carcinomas of the breast, colon, larynx, lymphoma and testis. Expression decreases during senescence of embryonic fibroblasts. Expression peaks at the G1/S phase boundary. Expression is induced by E2F1, E2F2 and E2F3. Expression is reduced in cells subject to numerous types of stress including UV-, IR- and bleomycin-induced DNA damage and by activation of p53. It has been reported that phosphorylation by AKT1 on S21 reduces methyltransferase activity.

Protein type: Methyltransferase, protein lysine; Methyltransferase; EC 2.1.1.43

Cellular Component: nucleoplasm; ESC/E(Z) complex; pronucleus; cytoplasm; nuclear chromatin; nucleus

Molecular Function: histone methyltransferase activity; sequence-specific DNA binding; RNA binding; chromatin DNA binding; chromatin binding; histone-lysine N-methyltransferase activity

Biological Process: negative regulation of striated muscle cell differentiation; regulation of protein amino acid phosphorylation; regulation of gliogenesis; hippocampus development; negative regulation of transcription from RNA polymerase II promoter; satellite cell compartment self-renewal involved in skeletal muscle regeneration; regulation of circadian rhythm; response to estradiol stimulus; regulation of cell proliferation; histone methylation; regulation of transcription from RNA polymerase II promoter; positive regulation of MAP kinase activity; cerebellar cortex development; negative regulation of retinoic acid receptor signaling pathway; regulation of neurogenesis; regulation of gene expression; negative regulation of gene expression, epigenetic; negative regulation of epidermal cell differentiation; DNA methylation; negative regulation of transcription, DNA-dependent